Tag: Quest Diagnostics

We're There

We’re There When You Need Us™ May champion

May 14, 2013

Nadine Larson, Certifying Scientist, discusses how Quest recognizes the importance of drug testing and that our test results impact people’s lives.

News

Name that drug: Methadone

May 13, 2013

The Name that Drug column in DATIA Focus magazine asks readers to guess the mystery substance. Did you know it was methadone?

New to Drug Testing

New to drug testing: A 52-week journey

May 9, 2013

During my first year of employment, I’m going to write a weekly column highlighting drug testing procedures, products & processes as I discover them.

We're There

Industry support shows We’re There values

April 16, 2013

2013 marked the 2nd year in a row that Quest Diagnostics has been sponsor of the Drug and Alcohol Testing Industry Association (DATIA) Conference.

Illicit drugs

Marijuana and prescription drug misuse in America

April 9, 2013

This new report details that individuals who use marijuana recreationally are more likely to misuse other drugs.

Oral Fluid testing

Oral-Eze offers superior detection of recent drug use

April 8, 2013

Oral fluid drug tests offer superior detection of recent drug use and are minimally invasive, making them more convenient for donors and collectors.

News

Upcoming DATIA conference

April 3, 2013

Quest Diagnostics will be exhibiting at this year’s Drug and Alcohol Testing Industry Association (DATIA) annual conference in Orlando, April 9 - 11.

News

Drug testing industry roundtable features Bob McCormick

March 29, 2013

Bob McCormick, VP of Employer Solutions at Quest Diagnostics, comments on the growth and future of drug testing and prescription drug monitoring.

News

Forensic toxicology fellowship

March 29, 2013

On behalf of Quest Diagnostics, I’m excited to announce to announce that we will be beginning a Post-Doctoral Fellowship in Forensic Toxicology.

Drug Testing

Pre-employment drug test positives increase more than 5%

March 8, 2013

The Drug Testing Index, an industry standard, examines positivity rates to provide a comprehensive analysis of workplace drug-use trends.